Inovio Pharmaceuticals, Inc. (INO)
NASDAQ · Healthcare
Inovio Pharmaceuticals, Inc. Operating Income 2009–2025
Inovio Pharmaceuticals, Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Inovio Pharmaceuticals, Inc. operating income for the quarter ending March 31, 2026 was -21.9 M, a 12.38% decrease year-over-year.
- Inovio Pharmaceuticals, Inc. operating income for the twelve months ending March 31, 2026 was -91.3 M, a 28.44% decrease year-over-year.
- Inovio Pharmaceuticals, Inc. annual operating income for 2025 was -86.8 M, a 22.76% decrease from 2024.
- Inovio Pharmaceuticals, Inc. annual operating income for 2024 was -112.4 M, a 21.91% decrease from 2023.
- Inovio Pharmaceuticals, Inc. annual operating income for 2023 was -143.9 M, a 46.21% decrease from 2022.
- Inovio Pharmaceuticals, Inc. annual operating income for 2022 was -267.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Inovio Pharmaceuticals, Inc. Operating Income — FAQ
Inovio Pharmaceuticals, Inc. (INO) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Inovio Pharmaceuticals, Inc.'s operating income?
Inovio Pharmaceuticals, Inc. (INO) reported operating income of -$87M for fiscal 2025.
Where can I see INO's operating income history?
The chart and table above show Inovio Pharmaceuticals, Inc.'s operating income by year and by quarter, including the growth rate.